PDCD1 and lung carcinoma: Our study successfully demonstrated that the overexpression of FLT3LG in a C57BL/6 mouse model of lung cancer effectively inhibited tumor growth, increased the infiltration of immune cells in the TME, enhanced the activity of various immune cells within the spleen, and improved the therapeutic efficacy of the PD-1 antibody.